Defective Drugs Comments Off on Drug Risk Resource Center Alerts Female Patients About Yaz®
The Drug Risk Resource Center, a group that works to bring awareness about the risks of various types of medications, has noted that both the generic and name-brand versions of Yaz®, an oral contraceptive manufactured by Bayer, has been linked to a high level of risk for blood clots, heart attacks, and strokes. Bayer is currently in settlement negotiations with many of the victims of these side effects.
History of Yaz® Lawsuits
Yaz® was introduced as a “third generation” progestin birth control method in the 1990s. These drugs were marketed as lower-risk for patients who used oral contraceptives. They appeared to have less side effects than the androgenic drugs that had been marketed earlier.
However, studies soon showed that progestin birth control actually carried a higher risk for blood clots, especially deep vein thromboses or DVTs and pulmonary embolisms, or clots in the lungs. The FDA required the makers of these drugs to include warnings to users of potential risks.
The American College of Obstetricians and Gynecologists also released information that birth control pills containing drospirenone could pose an even higher risk of blood clots. This means that Yaz® and its other forms such as Yasmin® and Ocella®, could cause a much greater risk of these serious and sometimes deadly side effects.
A University of Copenhagen study released in October of 2011 linked the hormones found in Yaz® to blood clots. At the same time, the FDA released a study, “Combined Hormonal Contraceptives and the Risk of Cardiovascular Disease Endpoints,” that indicated that drugs such as Yaz® could result in a risk of blood clots that was 74 percent greater than the risk level for non-users.
Because of the lack of warning given to potential users and the resulting rise in serious side effects from taking these drugs, lawsuits are now being filed to compensate victims. These lawsuits are part of a product liability claim that is based on false advertising and lack of information given by the manufacturer about these drugs.
Victims who have suffered blood clots, DVTs, or pulmonary embolisms after taking these drugs may now be entitled to compensation from the manufacturers due to the fact that the drugs have caused serious side effects and even deaths in some patients.
Can I File A Yaz® Lawsuit?
Any woman who has suffered a pulmonary embolism, DVT, or blood clot as the result of taking Yaz® or another form of the drug may be entitled to file a lawsuit for compensation. Bayer has already set aside $750 million to settle the lawsuits arising from these drugs.
In order to facilitate the large number of expected claims, Yaz® lawsuits were consolidated into what is known as a class action or mass tort lawsuit. In order to be a part of this lawsuit, victims must contact a personal injury attorney and discuss their rights with a lawyer. By becoming a part of the Yaz® lawsuit, victims may be eligible to receive compensation for their injuries resulting from the use of Yaz® or a generic version of the drug.